Skip to main content

Table 3 Demographic data of individuals with antemortem CSF assessment

From: NG2 cells, a new trail for Alzheimer’s disease mechanisms?

Characteristics

Control (n=36)

AD (n=47)

M/F (n)

17 / 19

13 / 34

Age at investigation (yrs)

61 ± 9

*** 77 ± 7

MMSE

28 ± 1

*** 20 ± 4

APOEϵ4 carriers (%)1,#

31

77

Aβ1–42 (ng/L)

659 ± 230

*** 355 ± 100

T-Tau (ng/L)

279 ± 136

*** 821 ± 322

P-Tau (ng/L)2

47 ± 19

*** 104 ± 39

NG2 (μg/ml)3

1.90 ± 0.07

*1.63 ± 0. 06

  1. Data are presented as mean± SD. 1Data missing on n=2 control. 2 Data missing on n=2 control, n=10 AD. # Individuals carrying one or two APOEϵ4 alleles. *** Indicates a significant difference at the p<0.001 level compared to controls using ANOVA. 3Results are age-adjusted. * Indicates a significant difference at the p<0.05 level compared to controls using ANCOVA.